Table 3 FUMA gene set enrichment analysis results of KEGG pathways for identified associations (Adjusted P value < 0.05)
Name | P value | Adjusted P value |
|---|---|---|
Hip area vs. SCZ | ||
 KEGG_AXON_GUIDANCE | 1.686 × 10−4 | 3.136 × 10−2 |
Hip total BMD vs. SCZ | ||
 KEGG_AXON_GUIDANCE | 8.719E × 10−5 | 1.622 × 10−2 |
Hip neck Area vs. SCZ | ||
 KEGG_GAP_JUNCTION | 2.239 × 10−4 | 2.157 × 10−2 |
 KEGG_CALCIUM_SIGNALING_PATHWAY | 3.006 × 10−4 | 2.157 × 10−2 |
 KEGG_GNRH_SIGNALING_PATHWAY | 3.480 × 10−4 | 2.157 × 10−2 |
Hip neck BMD vs. SCZ | ||
 KEGG_ASCORBATE_AND_ALDARATE_METABOLISM | 9.782 × 10−7 | 1.462 × 10−4 |
 KEGG_PENTOSE_AND_GLUCURONATE_INTERCONVERSIONS | 1.572 × 10−6 | 1.462 × 10−4 |
 KEGG_PORPHYRIN_AND_CHLOROPHYLL_METABOLISM | 7.543 × 10−6 | 4.677 × 10−4 |
 KEGG_DRUG_METABOLISM_OTHER_ENZYMES | 1.818 × 10−5 | 7.310 × 10−4 |
 KEGG_STARCH_AND_SUCROSE_METABOLISM | 1.965 × 10−5 | 7.310 × 10−4 |
 KEGG_STEROID_HORMONE_BIOSYNTHESIS | 2.458 × 10−5 | 7.621 × 10−4 |
 KEGG_RETINOL_METABOLISM | 4.485 × 10−5 | 1.192 × 10−3 |
 KEGG_METABOLISM_OF_XENOBIOTICS_BY_CYTOCHROME_P450 | 6.381 × 10−5 | 1.473 × 10−3 |
 KEGG_DRUG_METABOLISM_CYTOCHROME_P450 | 7.127 × 10−5 | 1.473 × 10−3 |
Spine area vs. SCZ | ||
 KEGG_NEUROACTIVE_LIGAND_RECEPTOR_INTERACTION | 3.722 × 10−6 | 6.922 × 10−4 |
 KEGG_NON_SMALL_CELL_LUNG_CANCER | 1.615 × 10−5 | 1.501 × 10−3 |
 KEGG_ARRHYTHMOGENIC_RIGHT_VENTRICULAR_CARDIOMYOPATHY_ARVC | 9.799 × 10−5 | 6.076 × 10−3 |
 KEGG_CALCIUM_SIGNALING_PATHWAY | 4.238 × 10−4 | 1.971 × 10−2 |
 KEGG_VALINE_LEUCINE_AND_ISOLEUCINE_DEGRADATION | 9.590 × 10−4 | 3.567 × 10−2 |
 KEGG_GLYCEROLIPID_METABOLISM | 1.440 × 10−3 | 4.107 × 10−2 |
 KEGG_ECM_RECEPTOR_INTERACTION | 1.545 × 10−3 | 4.107 × 10−2 |
 KEGG_DILATED_CARDIOMYOPATHY | 2.096 × 10−3 | 4.874 × 10−2 |
Ulna & radius area vs. SCZ | ||
 KEGG_NEUROACTIVE_LIGAND_RECEPTOR_INTERACTION | 1.492 × 10−4 | 2.775 × 10−2 |